Literatures

Primary Site >> Liver Cancer

Gene >> FGF19

1.
Journal:	Am J Pathol. 2002 Jun;160(6):2295-307.
Title:	A mouse model of hepatocellular carcinoma: ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice.
Author:	Nicholes, Katrina\|Guillet, Susan\|Tomlinson, Elizabeth\|Hillan, Kenneth\|Wright, Barbara\|Frantz, Gretchen D\|Pham, Thinh A\|Dillard-Telm, Lisa\|Tsai, Siao Ping\|Stephan, Jean-Philippe\|Stinson, Jeremy\|Stewart, Timothy\|French, Dorothy M
PMID:	12057932

2.
Journal:	Int J Oncol. 2005 Jul;27(1):281-5.
Title:	Comparative genomics on mammalian Fgf3-Fgf4 locus.
Author:	Katoh, Masuko\|Katoh, Masaru
PMID:	15942670

3.
Journal:	Oncogene. 2008 Jan 3;27(1):85-97.
Title:	Targeting FGF19 inhibits tumor growth in colon cancer xenograft and FGF19 transgenic hepatocellular carcinoma models.
Author:	Desnoyers, L R\|Pai, R\|Ferrando, R E\|Hotzel, K\|Le, T\|Ross, J\|Carano, R\|D'Souza, A\|Qing, J\|Mohtashemi, I\|Ashkenazi, A\|French, D M
PMID:	17599042

4.
Journal:	Mol Pharm. 2008 Jan-Feb;5(1):42-8.
Title:	Mini-review: endocrine actions of fibroblast growth factor 19.
Author:	Jones, Stacey
PMID:	18179175

5.
Journal:	J Biol Chem. 2010 Feb 19;285(8):5165-70.
Title:	FGF19-induced hepatocyte proliferation is mediated through FGFR4 activation.
Author:	Wu, Xinle\|Ge, Hongfei\|Lemon, Bryan\|Vonderfecht, Steven\|Weiszmann, Jennifer\|Hecht, Randy\|Gupte, Jamila\|Hager, Todd\|Wang, Zhulun\|Lindberg, Richard\|Li, Yang
PMID:	20018895

6.
Journal:	J Biol Chem. 2010 Sep 24;285(39):30069-78.
Title:	Metabolic regulator betaKlotho interacts with fibroblast growth factor receptor 4 (FGFR4) to induce apoptosis and inhibit tumor cell proliferation.
Author:	Luo, Yongde\|Yang, Chaofeng\|Lu, Weiqin\|Xie, Rui\|Jin, Chengliu\|Huang, Peng\|Wang, Fen\|McKeehan, Wallace L
PMID:	20657013

7.
Journal:	Cancer Cell. 2011 Mar 8;19(3):347-58.
Title:	Identification of a therapeutic strategy targeting amplified FGF19 in liver cancer by Oncogenomic screening.
Author:	Sawey, Eric T\|Chanrion, Maia\|Cai, Chunlin\|Wu, Guanming\|Zhang, Jianping\|Zender, Lars\|Zhao, Alice\|Busuttil, Ronald W\|Yee, Herman\|Stein, Lincoln\|French, Dorothy M\|Finn, Richard S\|Lowe, Scott W\|Powers, Scott
PMID:	21397858

8.
Journal:	Toxicol Sci. 2012 Apr;126(2):446-56.
Title:	Antibody-mediated inhibition of fibroblast growth factor 19 results in increased bile acids synthesis and ileal malabsorption of bile acids in cynomolgus monkeys.
Author:	Pai, Rama\|French, Dorothy\|Ma, Ning\|Hotzel, Kathy\|Plise, Emile\|Salphati, Laurent\|Setchell, Kenneth D R\|Ware, Joseph\|Lauriault, Veronique\|Schutt, Leah\|Hartley, Dylan\|Dambach, Donna
PMID:	22268002

9.
Journal:	BMC Cancer. 2012 Feb 6;12:56.
Title:	Fibroblast growth factor 19 expression correlates with tumor progression and poorer prognosis of hepatocellular carcinoma.
Author:	Miura, Seiki\|Mitsuhashi, Noboru\|Shimizu, Hiroaki\|Kimura, Fumio\|Yoshidome, Hiroyuki\|Otsuka, Masayuki\|Kato, Atsushi\|Shida, Takashi\|Okamura, Daiki\|Miyazaki, Masaru
PMID:	22309595

10.
Journal:	Adv Exp Med Biol. 2012;728:183-94.
Title:	FGF19 and cancer.
Author:	Lin, Benjamin C\|Desnoyers, Luc R
PMID:	22396170

11.
Journal:	Adv Exp Med Biol. 2012;728:195-213.
Title:	Understanding the structure-function relationship between FGF19 and its mitogenic and metabolic activities.
Author:	Wu, Xinle\|Li, Yang
PMID:	22396171

12.
Journal:	PLoS One. 2012;7(5):e36713.
Title:	Targeting FGFR4 inhibits hepatocellular carcinoma in preclinical mouse models.
Author:	French, Dorothy M\|Lin, Benjamin C\|Wang, Manping\|Adams, Camellia\|Shek, Theresa\|Hotzel, Kathy\|Bolon, Brad\|Ferrando, Ronald\|Blackmore, Craig\|Schroeder, Kurt\|Rodriguez, Luis A\|Hristopoulos, Maria\|Venook, Rayna\|Ashkenazi, Avi\|Desnoyers, Luc R
PMID:	22615798

13.
Journal:	PLoS One. 2012;7(12):e52711.
Title:	Regulation of amphiregulin gene expression by beta-catenin signaling in human hepatocellular carcinoma cells: a novel crosstalk between FGF19 and the EGFR system.
Author:	Latasa, Maria U\|Salis, Fabiana\|Urtasun, Raquel\|Garcia-Irigoyen, Oihane\|Elizalde, Maria\|Uriarte, Iker\|Santamaria, Monica\|Feo, Francesco\|Pascale, Rosa M\|Prieto, Jesus\|Berasain, Carmen\|Avila, Matias A
PMID:	23285165

14.
Journal:	Dig Dis Sci. 2013 Jul;58(7):1916-22.
Title:	Expression of fibroblast growth factor 19 is associated with recurrence and poor prognosis of hepatocellular carcinoma.
Author:	Hyeon, Jiyeon\|Ahn, Soomin\|Lee, Jae Jun\|Song, Dae Hyun\|Park, Cheol-Keun
PMID:	23456506

15.
Journal:	World J Gastroenterol. 2013 Dec 21;19(47):8873-9.
Title:	Target genes discovery through copy number alteration analysis in human hepatocellular carcinoma.
Author:	Gu, De-Leung\|Chen, Yen-Hsieh\|Shih, Jou-Ho\|Lin, Chi-Hung\|Jou, Yuh-Shan\|Chen, Chian-Feng
PMID:	24379610

16.
Journal:	Liver Int. 2014 Jul;34(6):e1-9.
Title:	Targeted inhibition of the FGF19-FGFR4 pathway in hepatocellular carcinoma; translational safety considerations.
Author:	Mellor, Howard R
PMID:	24393342

17.
Journal:	Curr Opin Lipidol. 2014 Apr;25(2):140-7.
Title:	Regulation of bile acid homeostasis by the intestinal Diet1-FGF15/19 axis.
Author:	Reue, Karen\|Lee, Jessica M\|Vergnes, Laurent
PMID:	24535283

18.
Journal:	Clin Cancer Res. 2014 Apr 15;20(8):2072-9.
Title:	Hepatocellular carcinoma: reasons for phase III failure and novel perspectives on trial design.
Author:	Llovet, Josep M\|Hernandez-Gea, Virginia
PMID:	24589894

19.
Journal:	Cancer Res. 2014 Jun 15;74(12):3306-16.
Title:	Separating Tumorigenicity from Bile Acid Regulatory Activity for Endocrine Hormone FGF19.
Author:	Zhou, Mei\|Wang, Xueyan\|Phung, Van\|Lindhout, Darrin A\|Mondal, Kalyani\|Hsu, Jer-Yuan\|Yang, Hong\|Humphrey, Mark\|Ding, Xunshan\|Arora, Taruna\|Learned, R Marc\|DePaoli, Alex M\|Tian, Hui\|Ling, Lei
PMID:	24728076

20.
Journal:	Hepatology. 2014 Dec;60(6):1972-82.
Title:	Genomic portrait of resectable hepatocellular carcinomas: implications of RB1 and FGF19 aberrations for patient stratification.
Author:	Ahn, Sung-Min\|Jang, Se Jin\|Shim, Ju Hyun\|Kim, Deokhoon\|Hong, Seung-Mo\|Sung, Chang Ohk\|Baek, Daehyun\|Haq, Farhan\|Ansari, Adnan Ahmad\|Lee, Sun Young\|Chun, Sung-Min\|Choi, Seongmin\|Choi, Hyun-Jeung\|Kim, Jongkyu\|Kim, Sukjun\|Hwang, Shin\|Lee, Young-Joo\|Lee, Jong
PMID:	24798001

21.
Journal:	Oncotarget. 2014 May 30;5(10):3012-22.
Title:	Identification of novel therapeutic targets in the PI3K/AKT/mTOR pathway in hepatocellular carcinoma using targeted next generation sequencing.
Author:	Janku, Filip\|Kaseb, Ahmed O\|Tsimberidou, Apostolia M\|Wolff, Robert A\|Kurzrock, Razelle
PMID:	24931142

22.
Journal:	Diseases. 2015 Oct 28;3(4):294-305.
Title:	Targeting FGF19/FGFR4 Pathway: A Novel Therapeutic Strategy for Hepatocellular Carcinoma.
Author:	Repana, Dimitra\|Ross, Paul
PMID:	28943626

23.
Journal:	Clin Res Hepatol Gastroenterol. 2015 Sep;39 Suppl 1:S80-5.
Title:	New molecular therapies for hepatocellular carcinoma.
Author:	Torrecilla, S\|Llovet, J M
PMID:	26206572

24.
Journal:	Gastroenterology. 2015 Oct;149(5):1226-1239.e4.
Title:	Genetic Landscape and Biomarkers of Hepatocellular Carcinoma.
Author:	Zucman-Rossi, Jessica\|Villanueva, Augusto\|Nault, Jean-Charles\|Llovet, Josep M
PMID:	26099527

25.
Journal:	Cancer Discov. 2015 Apr;5(4):355-7.
Title:	Paralog-Specific Kinase Inhibition of FGFR4: Adding to the Arsenal of Anti-FGFR Agents.
Author:	Packer, Leisl M\|Pollock, Pamela M
PMID:	25847957

26.
Journal:	Nat Genet. 2015 May;47(5):505-511.
Title:	Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets.
Author:	Schulze, Kornelius\|Imbeaud, Sandrine\|Letouze, Eric\|Alexandrov, Ludmil B\|Calderaro, Julien\|Rebouissou, Sandra\|Couchy, Gabrielle\|Meiller, Clement\|Shinde, Jayendra\|Soysouvanh, Frederic\|Calatayud, Anna-Line\|Pinyol, Roser\|Pelletier, Laura\|Balabaud, Charles\|Lau
PMID:	25822088

27.
Journal:	Hepatology. 2015 Oct;62(4):1324.
Title:	Targeting FGF19 binding to its receptor system: a novel therapeutic approach for hepatocellular carcinoma.
Author:	Panera, Nadia\|Ceccarelli, Sara\|Nobili, Valerio\|Alisi, Anna
PMID:	25677789

28.
Journal:	Cancer Discov. 2015 Apr;5(4):424-37.
Title:	First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway.
Author:	Hagel, Margit\|Miduturu, Chandra\|Sheets, Michael\|Rubin, Nooreen\|Weng, Weifan\|Stransky, Nicolas\|Bifulco, Neil\|Kim, Joseph L\|Hodous, Brian\|Brooijmans, Natasja\|Shutes, Adam\|Winter, Christopher\|Lengauer, Christoph\|Kohl, Nancy E\|Guzi, Timothy
PMID:	25776529

29.
Journal:	Int J Cancer. 2015 May 15;136(10):2469-75.
Title:	Ileal FGF15 contributes to fibrosis-associated hepatocellular carcinoma development.
Author:	Uriarte, Iker\|Latasa, M Ujue\|Carotti, Simone\|Fernandez-Barrena, Maite G\|Garcia-Irigoyen, Oihane\|Elizalde, Maria\|Urtasun, Raquel\|Vespasiani-Gentilucci, Umberto\|Morini, Sergio\|de Mingo, Alvaro\|Mari, Montserrat\|Corrales, Fernando J\|Prieto, Jesus\|Berasain, Ca
PMID:	25346390

30.
Journal:	Expert Opin Ther Targets. 2015 May;19(5):675-85.
Title:	Targeting fibroblast growth factor 19 in liver disease: a potential biomarker and therapeutic target.
Author:	Liu, Wen-Yue\|Xie, Dong-Mei\|Zhu, Gui-Qi\|Huang, Gui-Qian\|Lin, Yi-Qian\|Wang, Li-Ren\|Shi, Ke-Qing\|Hu, Bin\|Braddock, Martin\|Chen, Yong-Ping\|Zheng, Ming-Hua
PMID:	25547779

31.
Journal:	Nat Commun. 2015 Jan 22;6:6087.
Title:	Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma.
Author:	Sia, Daniela\|Losic, Bojan\|Moeini, Agrin\|Cabellos, Laia\|Hao, Ke\|Revill, Kate\|Bonal, Dennis\|Miltiadous, Oriana\|Zhang, Zhongyang\|Hoshida, Yujin\|Cornella, Helena\|Castillo-Martin, Mireia\|Pinyol, Roser\|Kasai, Yumi\|Roayaie, Sasan\|Thung, Swan N\|Fuster, Josep\|Schw
PMID:	25608663

32.
Journal:	Oncotarget. 2016 Mar 22;7(12):13575-86.
Title:	FGF19 promotes epithelial-mesenchymal transition in hepatocellular carcinoma cells by modulating the GSK3beta/beta- catenin signaling cascade via FGFR4 activation.
Author:	Zhao, Huakan\|Lv, Fenglin\|Liang, Guizhao\|Huang, Xiaobin\|Wu, Gang\|Zhang, Wenfa\|Yu, Le\|Shi, Lei\|Teng, Yong
PMID:	26498355

33.
Journal:	Hepatology. 2016 Oct;64(4):1289-301.
Title:	Mechanistic target of rapamycin complex 1 is an essential mediator of metabolic and mitogenic effects of fibroblast growth factor 19 in hepatoma cells.
Author:	Wan, Zhi Yi\|Tian, Johann Shane\|Tan, Hayden Weng Siong\|Chow, Ai Lee\|Sim, Arthur Yi Loong\|Ban, Kenneth Hon Kim\|Long, Yun Chau
PMID:	27178107

34.
Journal:	Int J Oncol. 2016 Aug;49(2):589-602.
Title:	Whole-genome DNA methylation and hydroxymethylation profiling for HBV-related hepatocellular carcinoma.
Author:	Ye, Chao\|Tao, Ran\|Cao, Qingyi\|Zhu, Danhua\|Wang, Yini\|Wang, Jie\|Lu, Juan\|Chen, Ermei\|Li, Lanjuan
PMID:	27221337

35.
Journal:	Genes Cancer. 2016 Mar;7(3-4):125-35.
Title:	FGF19 functions as autocrine growth factor for hepatoblastoma.
Author:	Elzi, David J\|Song, Meihua\|Blackman, Barron\|Weintraub, Susan T\|Lopez-Terrada, Dolores\|Chen, Yidong\|Tomlinson, Gail E\|Shiio, Yuzuru
PMID:	27382436

36.
Journal:	Oncotarget. 2016 Aug 2;7(31):49091-49098.
Title:	Increased FGF19 copy number is frequently detected in hepatocellular carcinoma with a complete response after sorafenib treatment.
Author:	Kaibori, Masaki\|Sakai, Kazuko\|Ishizaki, Morihiko\|Matsushima, Hideyuki\|De Velasco, Marco A\|Matsui, Kosuke\|Iida, Hiroya\|Kitade, Hiroaki\|Kwon, A-Hon\|Nagano, Hiroaki\|Wada, Hiroshi\|Haji, Seiji\|Tsukamoto, Tadashi\|Kanazawa, Akishige\|Takeda, Yutaka\|Takemura, Shig
PMID:	27384874

37.
Journal:	Oncotarget. 2016 Aug 9;7(32):52329-52339.
Title:	Up-regulation of fibroblast growth factor 19 and its receptor associates with progression from fatty liver to hepatocellular carcinoma.
Author:	Li, Yan\|Zhang, Weizhong\|Doughtie, Anne\|Cui, Guozhen\|Li, Xuanyi\|Pandit, Harshul\|Yang, Yingbin\|Li, Suping\|Martin, Robert
PMID:	27447573

38.
Journal:	Hepatol Commun. 2017 Oct 16;1(10):1024-1042.
Title:	Engineered FGF19 eliminates bile acid toxicity and lipotoxicity leading to resolution of steatohepatitis and fibrosis in mice.
Author:	Zhou, Mei\|Learned, R Marc\|Rossi, Stephen J\|DePaoli, Alex M\|Tian, Hui\|Ling, Lei
PMID:	29404440

39.
Journal:	Cancer Res. 2017 Dec 15;77(24):6999-7013.
Title:	H3B-6527 Is a Potent and Selective Inhibitor of FGFR4 in FGF19-Driven Hepatocellular Carcinoma.
Author:	Joshi, Jaya Julie\|Coffey, Heather\|Corcoran, Erik\|Tsai, Jennifer\|Huang, Chia-Ling\|Ichikawa, Kana\|Prajapati, Sudeep\|Hao, Ming-Hong\|Bailey, Suzanna\|Wu, Jeremy\|Rimkunas, Victoria\|Karr, Craig\|Subramanian, Vanitha\|Kumar, Pavan\|MacKenzie, Crystal\|Hurley, Raelene
PMID:	29247039

40.
Journal:	Cancer Res. 2017 Nov 15;77(22):6215-6225.
Title:	FGF19 Protects Hepatocellular Carcinoma Cells against Endoplasmic Reticulum Stress via Activation of FGFR4-GSK3beta-Nrf2 Signaling.
Author:	Teng, Yong\|Zhao, Huakan\|Gao, Lixia\|Zhang, Wenfa\|Shull, Austin Y\|Shay, Chloe
PMID:	28951455

41.
Journal:	J Hepatol. 2017 Oct;67(4):727-738.
Title:	Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification.
Author:	Calderaro, Julien\|Couchy, Gabrielle\|Imbeaud, Sandrine\|Amaddeo, Giuliana\|Letouze, Eric\|Blanc, Jean-Frederic\|Laurent, Christophe\|Hajji, Yacine\|Azoulay, Daniel\|Bioulac-Sage, Paulette\|Nault, Jean-Charles\|Zucman-Rossi, Jessica
PMID:	28532995

42.
Journal:	Nat Commun. 2017 May 16;8:15433.
Title:	Non-cell-autonomous activation of IL-6/STAT3 signaling mediates FGF19-driven hepatocarcinogenesis.
Author:	Zhou, Mei\|Yang, Hong\|Learned, R Marc\|Tian, Hui\|Ling, Lei
PMID:	28508871

43.
Journal:	Dig Dis. 2017;35(3):158-165.
Title:	Fibroblast Growth Factor 15/19 in Hepatocarcinogenesis.
Author:	Alvarez-Sola, Gloria\|Uriarte, Iker\|Latasa, M Ujue\|Urtasun, Raquel\|Barcena-Varela, Marina\|Elizalde, Maria\|Jimenez, Maddalen\|Rodriguez-Ortigosa, Carlos M\|Corrales, Fernando J\|Fernandez-Barrena, Maite G\|Berasain, Carmen\|Avila, Matias A
PMID:	28249259

44.
Journal:	Oncotarget. 2017 Jun 13;8(24):38592-38601.
Title:	Multiplexed gene expression profiling identifies the FGFR4 pathway as a novel biomarker in intrahepatic cholangiocarcinoma.
Author:	Yoo, Changhoon\|Kang, Jihoon\|Kim, Deokhoon\|Kim, Kyu-Pyo\|Ryoo, Baek-Yeol\|Hong, Seung-Mo\|Hwang, Jung Jin\|Jeong, Seong-Yun\|Hwang, Shin\|Kim, Ki-Hun\|Lee, Young-Joo\|Hoeflich, Klaus P\|Schmidt-Kittler, Oleg\|Miller, Stephen\|Choi, Eun Kyung
PMID:	28445152

45.
Journal:	J Hepatol. 2017 Jun;66(6):1182-1192.
Title:	Mouse species-specific control of hepatocarcinogenesis and metabolism by FGF19/FGF15.
Author:	Zhou, Mei\|Luo, Jian\|Chen, Michael\|Yang, Hong\|Learned, R Marc\|DePaoli, Alex M\|Tian, Hui\|Ling, Lei
PMID:	28189755

46.
Journal:	PLoS One. 2017 Feb 8;12(2):e0171185.
Title:	Quantitative liver proteomics identifies FGF19 targets that couple metabolism and proliferation.
Author:	Massafra, Vittoria\|Milona, Alexandra\|Vos, Harmjan R\|Burgering, Boudewijn M T\|van Mil, Saskia W C
PMID:	28178326

47.
Journal:	J Exp Clin Cancer Res. 2017 Jan 9;36(1):8.
Title:	FGF19/FGFR4 signaling contributes to the resistance of hepatocellular carcinoma to sorafenib.
Author:	Gao, Lixia\|Wang, Xuli\|Tang, Yaoliang\|Huang, Shuang\|Hu, Chien-An Andy\|Teng, Yong
PMID:	28069043

48.
Journal:	Mol Cancer Ther. 2017 Jan;16(1):68-75.
Title:	ASP5878, a Novel Inhibitor of FGFR1, 2, 3, and 4, Inhibits the Growth of FGF19-Expressing Hepatocellular Carcinoma.
Author:	Futami, Takashi\|Okada, Hidetsugu\|Kihara, Rumi\|Kawase, Tatsuya\|Nakayama, Ayako\|Suzuki, Tomoyuki\|Kameda, Minoru\|Shindoh, Nobuaki\|Terasaka, Tadashi\|Hirano, Masaaki\|Kuromitsu, Sadao
PMID:	27837028

49.
Journal:	Gastroenterology. 2017 Jan;152(1):232-242.e4.
Title:	Cell Culture System for Analysis of Genetic Heterogeneity Within Hepatocellular Carcinomas and Response to Pharmacologic Agents.
Author:	Gao, Qiang\|Wang, Zhi-Chao\|Duan, Meng\|Lin, Yi-Hui\|Zhou, Xue-Ya\|Worthley, Daniel L\|Wang, Xiao-Ying\|Niu, Gang\|Xia, Yuchao\|Deng, Minghua\|Liu, Long-Zi\|Shi, Jie-Yi\|Yang, Liu-Xiao\|Zhang, Shu\|Ding, Zhen-Bin\|Zhou, Jian\|Liang, Chun-Min\|Cao, Ya\|Xiong, Lei\|Xi, Ruibin
PMID:	27639803

50.
Journal:	Cell Oncol (Dordr). 2018 Feb;41(1):85-91.
Title:	Implications of FGF19 on sorafenib-mediated nitric oxide production in hepatocellular carcinoma cells - a short report.
Author:	Gao, Lixia\|Shay, Chloe\|Lv, Fenglin\|Wang, Xuli\|Teng, Yong
PMID:	28983785

51.
Journal:	Gene Expr. 2018 May 18;18(2):103-113.
Title:	Endocrine Adiponectin-FGF15/19 Axis in Ethanol-Induced Inflammation and Alcoholic Liver Injury.
Author:	You, Min\|Zhou, Zhou\|Daniels, Michael\|Jogasuria, Alvin
PMID:	29096734

52.
Journal:	Toxicol Sci. 2018 May 1;163(1):265-278.
Title:	Bile Acid Sequestration by Cholestyramine Mitigates FGFR4 Inhibition-Induced ALT Elevation.
Author:	Schadt, Heiko S\|Wolf, Armin\|Mahl, Joerg Andreas\|Wuersch, Kuno\|Couttet, Philippe\|Schwald, Marianne\|Fischer, Audrey\|Lienard, Mathilde\|Emotte, Corinne\|Teng, Chi-Hse\|Skuba, Elizabeth\|Richardson, Terrilyn A\|Manenti, Luigi\|Weiss, Andreas\|Graus Porta, Diana\|Fair
PMID:	29432567

53.
Journal:	Future Oncol. 2018 Mar;14(6):553-566.
Title:	Novel targeted therapy strategies for biliary tract cancers and hepatocellular carcinoma.
Author:	DeLeon, Thomas T\|Ahn, Daniel H\|Bogenberger, James M\|Anastasiadis, Panos Z\|Arora, Mansi\|Ramanathan, Ramesh K\|Aqel, Bashar A\|Vasmatzis, George\|Truty, Mark J\|Oklu, Rahmi\|Bekaii-Saab, Tanios S\|Borad, Mitesh J
PMID:	29460642

54.
Journal:	J Physiol Biochem. 2018 May;74(2):247-260.
Title:	The ileal FGF15/19 to hepatic FGFR4 axis regulates liver regeneration after partial hepatectomy in mice.
Author:	Li, Qiang\|Zhao, Qiang\|Zhang, Chuanzhao\|Zhang, Peng\|Hu, Anbin\|Zhang, Longjuan\|Schroder, Paul M\|Ma, Yi\|Guo, Zhiyong\|Zhu, Xiaofeng\|He, Xiaoshun
PMID:	29468415

55.
Journal:	Oncotarget. 2017 Nov 20;9(15):12471-12478.
Title:	Research progress on the forkhead box C1.
Author:	Wang, Jinhua\|Li, Wan\|Zheng, Xiangjin\|Pang, Xiaocong\|Du, Guanhua
PMID:	29552326

56.
Journal:	Cancer Med. 2018 Jun;7(6):2641-2653.
Title:	Lenvatinib inhibits angiogenesis and tumor fibroblast growth factor signaling pathways in human hepatocellular carcinoma models.
Author:	Matsuki, Masahiro\|Hoshi, Taisuke\|Yamamoto, Yuji\|Ikemori-Kawada, Megumi\|Minoshima, Yukinori\|Funahashi, Yasuhiro\|Matsui, Junji
PMID:	29733511

57.
Journal:	J Exp Clin Cancer Res. 2018 Jul 4;37(1):136.
Title:	Up-regulation of FGF15/19 signaling promotes hepatocellular carcinoma in the background of fatty liver.
Author:	Cui, Guozhen\|Martin, Robert C\|Jin, Hang\|Liu, Xingkai\|Pandit, Harshul\|Zhao, Hengjun\|Cai, Lu\|Zhang, Ping\|Li, Wei\|Li, Yan
PMID:	29973237

58.
Journal:	Curr Opin Pharmacol. 2018 Sep 14;43:93-98.
Title:	The gut-liver axis in hepatocarcinoma: a focus on the nuclear receptor FXR and the enterokine FGF19.
Author:	Piglionica, Marilidia\|Cariello, Marica\|Moschetta, Antonio
PMID:	30223181

59.
Journal:	Clin Cancer Res. 2018 Oct 29. pii: 1078-0432.CCR-18-2293.
Title:	Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next Generation Sequencing for Matching Patients to Targeted and Immune Therapies.
Author:	Harding, James J\|Nandakumar, Subhiksha\|Armenia, Joshua\|Khalil, Danny N\|Albano, Melanie\|Ly, Michele\|Shia, Jinru\|Hechtman, Jaclyn F\|Kundra, Ritika\|El Dika, Imane\|Do, Richard K\|Sun, Yichao\|Kingham, T Peter\|D'Angelica, Michael I\|Berger, Michael F\|Hyman, David
PMID:	30373752